Cutting edge: expression of functional CD137 receptor by dendritic cells

被引:188
作者
Wilcox, RA
Chapoval, AI
Gorski, KS
Otsuji, M
Shin, T
Flies, DB
Tamada, K
Mittler, RS
Tsuchiya, H
Pardoll, DM
Chen, LP
机构
[1] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[3] Emory Univ, Sch Med, Carlos & Marguerite Mason Transplantat Biol Res C, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA
关键词
D O I
10.4049/jimmunol.168.9.4262
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interaction between dendritic cells (DCs) and T cells is a prerequisite for the initiation of a T cell response. The molecular nature of this interaction remains to be fully characterized. We report in this work that freshly isolated mouse splenic DCs and bone marrow-derived DCs express CD137 on the cell surface and in soluble form. Triggering CD137 increased the secretion of IL-6 and IL-12 from DCs. More importantly, infusion of an agonistic mAb to CD137 into naive mice enhanced the ability of DCs to stimulate T cell proliferation in response to both alloantigens and a nominal Ag in vitro. This enhancement of DC function is not mediated through activation of T cells, because the effect was also observed in RAG-1 knockout mice that lack T cells. Our findings implicate CD137 as an important receptor involved in the modulation of DC function.
引用
收藏
页码:4262 / 4267
页数:6
相关论文
共 45 条
  • [1] TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation
    Bachmann, MF
    Wong, BR
    Josien, R
    Steinman, RM
    Oxenius, A
    Choi, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) : 1025 - 1031
  • [2] Immunobiology of dendritic cells
    Banchereau, J
    Briere, F
    Caux, C
    Davoust, J
    Lebecque, S
    Liu, YT
    Pulendran, B
    Palucka, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 767 - +
  • [3] Help for cytotoxic-T-cell responses is mediated by CD40 signalling
    Bennett, SRM
    Carbone, FR
    Karamalis, F
    Flavell, RA
    Miller, JFAP
    Heath, WR
    [J]. NATURE, 1998, 393 (6684) : 478 - 480
  • [4] Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients
    Blazar, BR
    Kwon, BS
    Panoskaltsis-Mortari, A
    Kwak, KB
    Peschon, JJ
    Taylor, PA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 3174 - 3183
  • [5] Buhlmann JE, 1999, J IMMUNOL, V162, P4373
  • [6] Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response
    Cannons, JL
    Choi, Y
    Watts, TH
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (11) : 6193 - 6204
  • [7] Cannons JL, 1999, J IMMUNOL, V163, P2990
  • [8] 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy
    Cannons, JL
    Lau, P
    Ghumman, B
    DeBenedette, MA
    Yagita, H
    Okumura, K
    Watts, TH
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1313 - 1324
  • [9] ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING
    CAUX, C
    MASSACRIER, C
    VANBERVLIET, B
    DUBOIS, B
    VANKOOTEN, C
    DURAND, I
    BANCHEREAU, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1263 - 1272
  • [10] Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation
    Chen, SH
    Pham-Nguyen, KB
    Martinet, O
    Huang, YZ
    Yang, W
    Thung, SN
    Chen, LP
    Mittler, R
    Woo, SLC
    [J]. MOLECULAR THERAPY, 2000, 2 (01) : 39 - 46